Davunetide studies: 90 papers with results
Page 2 of 2
- ADNP/NAP dramatically increase microtubule end-binding protein-Tau interaction: a novel avenue for protection against tauopathy.
Ivashko-Pachima Y · Molecular psychiatry · 2017
In vitro (cells) · 13 results
- The ADNP derived peptide, NAP modulates the tubulin pool: implication for neurotrophic and neuroprotective activities.
Oz S · PloS one · 2012
In vitro (cells) · rat · 7 results
- PolyADP-ribosylation is involved in neurotrophic activity.
Visochek L · The Journal of neuroscience : the official journal of the Society for Neuroscience · 2005
In vitro (cells) · rat · 3 results
- The femtomolar-acting NAP interacts with microtubules: Novel aspects of astrocyte protection.
Gozes I · Journal of Alzheimer's disease : JAD · 2004
In vitro (cells) · 6 results
- A novel peptide prevents death in enriched neuronal cultures.
Zemlyak I · Regulatory peptides · 2000
In vitro (cells) · rat · 4 results
- NAP, a neuroprotective drug candidate in clinical trials, stimulates microtubule assembly in the living cell.
Gozes I · Current Alzheimer research · 2007
In vitro (cells) · 3 results
- Activity-dependent neurotrophic factor-9 and NAP promote neurite outgrowth in rat hippocampal and cortical cultures.
Smith-Swintosky VL · Journal of molecular neuroscience : MN · 2005
In vitro (cells) · rat · 6 results
- NAP and D-SAL: neuroprotection against the beta amyloid peptide (1-42).
Gozes I · BMC neuroscience · 2008
In vitro (cells) · rat · 1 result
- NAP and ADNF-9 protect normal and Down's syndrome cortical neurons from oxidative damage and apoptosis.
Busciglio J · Current pharmaceutical design · 2007
In vitro (cells) · 5 results
- Ethanol inhibits neuronal differentiation by disrupting activity-dependent neuroprotective protein signaling.
Chen S · Proceedings of the National Academy of Sciences of the United States of America · 2008
In vitro (cells) · 3 results
- Peptide antagonists of ethanol inhibition of l1-mediated cell-cell adhesion.
Wilkemeyer MF · The Journal of pharmacology and experimental therapeutics · 2002
In vitro (cells) · 6 results
- Protective peptides that are orally active and mechanistically nonchiral.
Brenneman DE · The Journal of pharmacology and experimental therapeutics · 2004
In vitro (cells) · rat · 5 results
- NAP, a peptide derived from the activity-dependent neuroprotective protein, modulates macrophage function.
Quintana FJ · Annals of the New York Academy of Sciences · 2006
In vitro (cells) · 3 results
- Expression of activity-dependent neuroprotective protein in the immune system: possible functions and relevance to multiple sclerosis.
Braitch M · Neuroimmunomodulation · 2010
In vitro (cells) · 4 results
- NAP (davunetide) preferential interaction with dynamic 3-repeat Tau explains differential protection in selected tauopathies.
Ivashko-Pachima Y · PloS one · 2019
In vitro (cells) · 1 result
- A Novel iron-chelating derivative of the neuroprotective peptide NAPVSIPQ shows superior antioxidant and antineurodegenerative capabilities.
Blat D · Journal of medicinal chemistry · 2008
In vitro (cells) · 3 results
- Impairment of mitochondria dynamics by human A53T α-synuclein and rescue by NAP (davunetide) in a cell model for Parkinson's disease.
Melo TQ · Experimental brain research · 2017
In vitro (cells) · 1 result
- Vasoactive intestinal peptide and related molecules induce nitrite accumulation in the extracellular milieu of rat cerebral cortical cultures.
Ashur-Fabian O · Neuroscience letters · 2001
In vitro (cells) · rat · 6 results
- NAP protects against cytochrome c release: inhibition of the initiation of apoptosis.
Zemlyak I · European journal of pharmacology · 2009
In vitro (cells) · 2 results
- Tau and caspase 3 as targets for neuroprotection.
Idan-Feldman A · International journal of Alzheimer's disease · 2012
In vitro (cells) · 3 results
- NAP protects hippocampal neurons against multiple toxins.
Zemlyak I · Peptides · 2007
In vitro (cells) · rat · 3 results
- NAP reduces murine microvascular endothelial cells proliferation induced by hyperglycemia.
D'Amico AG · Journal of molecular neuroscience : MN · 2014
In vitro (cells) · mouse · 4 results
- Reduction of aluminum ion neurotoxicity through a small peptide application - NAP treatment of Alzheimer's disease.
Yang MH · Journal of food and drug analysis · 2019
In vitro (cells) · 2 results
- NAP (Davunetide): The Neuroprotective ADNP Drug Candidate Penetrates Cell Nuclei Explaining Pleiotropic Mechanisms.
Ganaiem M · Cells · 2023
In vitro (cells) · 4 results
- NAP protects against cyanide-related microtubule destruction.
Zemlyak I · Journal of neural transmission (Vienna, Austria : 1996) · 2009
In vitro (cells) · 1 result
- NAP (davunetide) protects primary hippocampus culture by modulating expression profile of antioxidant genes during limiting oxygen conditions.
Arya A · Free radical research · 2015
In vitro (cells) · rat · 1 result
- Novel neuroprotective neurotrophic NAP analogs targeting metal toxicity and oxidative stress: potential candidates for the control of neurodegenerative diseases.
Zheng H · Journal of neural transmission. Supplementum · 2006
In vitro (cell-free) · rat · 1 result
- Neuroprotective Peptide NAPVSIPQ Antagonizes Ethanol Inhibition of L1 Adhesion by Promoting the Dissociation of L1 and Ankyrin-G.
Dou X · Biological psychiatry · 2020
Other design · 5 results
- Neuroprotective peptides influence cytokine and chemokine alterations in a model of fetal alcohol syndrome.
Roberson R · American journal of obstetrics and gynecology · 2012
Not a test of Davunetide alone · 10 results
- Novel peptides prevent alcohol-induced spatial learning deficits and proinflammatory cytokine release in a mouse model of fetal alcohol syndrome.
Vink J · American journal of obstetrics and gynecology · 2005
Not a test of Davunetide alone · 9 results
- Prevention of developmental delays in a Down syndrome mouse model.
Toso L · Obstetrics and gynecology · 2008
Not a test of Davunetide alone · 6 results
- Expression of peptide NAP in rat retinal Müller cells prevents hypoxia-induced retinal injuries and promotes retinal neurons growth.
Zheng Y · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2010
Not a test of Davunetide alone · 4 results
- Prenatal NAP+SAL prevents developmental delay in a mouse model of Down syndrome through effects on N-methyl-D-aspartic acid and gamma-aminobutyric acid receptors.
Vink J · American journal of obstetrics and gynecology · 2009
Not a test of Davunetide alone · 4 results
- Prenatal treatment prevents learning deficit in Down syndrome model.
Incerti M · PloS one · 2012
Not a test of Davunetide alone · 3 results
- Vasoactive intestinal peptide mRNA and immunoreactivity are decreased in fetal alcohol syndrome model.
Spong CY · Regulatory peptides · 2002
Not a test of Davunetide alone · 3 results
- Neuroprotective peptides prevent some alcohol-induced alteration in gamma-aminobutyric acid A-beta3, which plays a role in cleft lip and palate and learning in fetal alcohol syndrome.
Toso L · American journal of obstetrics and gynecology · 2007
Not a test of Davunetide alone · 3 results
- The role of activity-dependent neuroprotective protein in a mouse model of fetal alcohol syndrome.
Poggi SH · American journal of obstetrics and gynecology · 2003
Not a test of Davunetide alone · 2 results
- Prevention of the alcohol-induced changes in brain-derived neurotrophic factor expression using neuroprotective peptides in a model of fetal alcohol syndrome.
Incerti M · American journal of obstetrics and gynecology · 2010
Not a test of Davunetide alone · 2 results
- Treatment with neuropeptides attenuates c-fos expression in a mouse model of fetal alcohol syndrome.
Incerti M · American journal of perinatology · 2010
Not a test of Davunetide alone · 2 results
- Integrating network, sequence and functional features using machine learning approaches towards identification of novel Alzheimer genes.
Jamal S · BMC genomics · 2016
Not a test of Davunetide alone · 1 result